Literature DB >> 31378268

Sterilization of Mycobacterium tuberculosis infected samples using methanol preserves anti-tuberculosis drugs for subsequent pharmacological testing studies.

Amanda Walz1, Pradeep B Lukka2, Camron Pearce1, Elizabeth Creissen1, Miriam Braunstein3, Anthony J Hickey4, Bernd Meibohm2, Mercedes Gonzalez-Juarrero5.   

Abstract

Pharmacokinetic/pharmacodynamic studies of anti-tuberculosis agents in animal models of tuberculosis are hampered by the frequent necessity to perform sample bioanalysis outside the biosafety level-3 environment. Thus, each specimen has to undergo tedious and time-consuming sample sterilization procedures that may also affect drug stability. Here, we tested treatment of Mycobacterium tuberculosis (Mtb) infected samples with methanol to sterilize samples while preserving drug integrity for further pharmacokinetic/pharmacodynamic evaluations. Tissue samples harvested from Mtb infected mice were homogenized, incubated in methanol, and tested for sterility. Once sterility was confirmed, the samples were used to determine concentrations of the anti-tuberculosis drug spectinamide-1599 in lung homogenates using liquid chromatography coupled with mass spectrometry. The results demonstrate that methanol sterilizes tissue samples harvested from Mtb infected mice without altering the integrity of the drug in the tissue.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Methanol; Mycobacterium-tuberculosis; PK; Pharmacokinetics; Sample sterilization

Mesh:

Substances:

Year:  2019        PMID: 31378268     DOI: 10.1016/j.tube.2019.06.002

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  1 in total

1.  Respirable Clofazimine Particles Produced by Air Jet Milling Technique Are Efficacious in Treatment of BALB/c Mice with Chronic Mycobacterium tuberculosis Infection.

Authors:  Ashlee D Brunaugh; Amanda Walz; Zachary Warnken; Camron Pearce; Juan Munoz Gutierrez; John J Koleng; Hugh D C Smyth; Mercedes Gonzalez-Juarrero
Journal:  Antimicrob Agents Chemother       Date:  2022-08-09       Impact factor: 5.938

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.